Afatinib Dimaleate

Afatinib Dimaleate (BIBW 2992MA2) is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.

Price Not Available 100 mg Afatinib Dimaleate Supplier Page

Catalog Number	T1773
Alternative Name(s)	Afatinib , BIBW 2992MA2 , Afatinib (BIBW2992) Dimaleate , BIBW2992
Research Area	JAK/STAT signaling\|\|\|Tyrosine Kinase/Adaptors\|\|\|Autophagy\|\|\|Angiogenesis
Molecular Formula	C32H33ClFN5O11
CAS#	850140-73-7
Purity	99.66%
SMILES	c12cc(c(cc1c(ncn2)Nc1cc(c(cc1)F)Cl)NC(=O)/C=C/CN(C)C)O[C@H]1CCOC1.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O
Size	100 mg
Supplier Page	https://www.targetmol.com/compound/Afatinib Dimaleate
Additional Information	https://www.targetmol.com/datasheet/T1773